The Indian Pharmaceutical Alliance (IPA) has proposed reducing the import duty on pharma products from the US to zero. Currently, India imposes a 10% tariff on US drugs, but the US does not charge any import duty on Indian drugs. This suggestion aims to support the Indian pharma industry by lowering costs.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/EmdaGLk
via IFTTT
No comments:
Post a Comment